REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Fehervar-Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Fehervar-Pharma Gyogyszerkiskereskedelmi Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Fehervar-Pharma Kft. is based in Hungary, with the head office in Budapest. It operates in the Pharmacies and Drug Stores sector. It was first established on December 17, 2007. It currently has a total number of 7 (2024) employees. From the latest financial highlights, Fehervar-Pharma Kft. reported a net sales revenue increase of 5.44% in 2023. A growth of 9.55% was recorded in its total assets. In 2023, Fehervar-Pharma Kft.’s net profit margin increased by 0.12%.

Headquarters
Konyves Kalman korut 12-14. (Lurdy Haz).
Budapest; Budapest; Postal Code: 1097

Contact Details: Purchase the Fehervar-Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Fehervar-Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Fehervar-Pharma Kft. report to view the information.
Registered Capital:
Purchase the Fehervar-Pharma Kft. report to view the information.
Financial Auditors:
Purchase the Fehervar-Pharma Kft. report to view the information.
Incorporation Date:
December 17, 2007
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Fehervar-Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
5.44%▲
Total operating revenue
5.24%▲
Operating profit (EBIT)
2.17%▲
EBITDA
2.51%▲
Net Profit (Loss) for the Period
6.49%▲
Total assets
9.55%▲
Total equity
6.33%▲
Operating Profit Margin (ROS)
-0.38%▼
Net Profit Margin
0.12%▲
Return on Equity (ROE)
0.15%▲
Quick Ratio
0.11%▲
Cash Ratio
0.22%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo